561.52
-7.37
(-1.30%)
At close: April 17 at 7:03:04 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 12 | 12 | 14 | 14 |
Avg. Estimate | 586.34M | 635.19M | 2.62B | 3.19B |
Low Estimate | 567.33M | 623.13M | 2.58B | 3.05B |
High Estimate | 606M | 655M | 2.67B | 3.36B |
Year Ago Sales | 460.74M | 504.1M | 2.08B | 2.62B |
Sales Growth (year/est) | 27.26% | 26.00% | 25.74% | 21.99% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0HKE.L | -- | -- | -- | -- |
S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
Maintains | Barclays: Overweight to Overweight | 2/27/2025 |
Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 2/26/2025 |
Reiterates | Needham: Buy to Buy | 2/26/2025 |
Downgrade | Craig-Hallum: Buy to Hold | 2/20/2025 |
Maintains | JMP Securities: Market Outperform to Market Outperform | 2/4/2025 |
Maintains | Goldman Sachs: Buy to Buy | 1/27/2025 |